Pulse Biosciences (PLSE) Non-Current Assets (2015 - 2025)

Pulse Biosciences has reported Non-Current Assets for 11 years, with the latest figure at $11.1 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 14.55% year-over-year to $11.1 million; the trailing twelve-month figure through Dec 2025 stood at $47.3 million (down 9.31% YoY), and the FY2025 full-year result was $11.1 million, down 14.55% from the prior year.
• Non-Current Assets for Q4 2025 stood at $11.1 million, down from $11.6 million in the prior quarter.
• The five-year high for Non-Current Assets was $18.6 million in Q1 2021, with the low at $11.1 million in Q4 2025.
• Average Non-Current Assets over 5 years is $14.6 million, with a median of $14.1 million recorded in 2021.
• Peak annual rise in Non-Current Assets reached 20.58% in 2021, while the deepest fall reached 27.05% in 2021.
• Tracing PLSE's Non-Current Assets over 5 years: stood at $13.8 million in 2021, then grew by 13.77% to $15.7 million in 2022, then retreated by 12.1% to $13.8 million in 2023, then retreated by 5.89% to $13.0 million in 2024, then retreated by 14.55% to $11.1 million in 2025.
• The last three Non-Current Assets figures came in at $11.1 million (Q4 2025), $11.6 million (Q3 2025), and $12.1 million (Q2 2025), per Business Quant data.

Peer Comparison